Clinical Trial Detail

NCT ID NCT02358200
Title Study of BMN-673 With Carboplatin and Paclitaxel in Patients With Advanced BRCA-mutated Solid Tumor or Triple Negative Metastatic Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

triple-receptor negative breast cancer

Advanced Solid Tumor

Therapies

Carboplatin + Paclitaxel + Talazoparib

Age Groups: adult senior

Additional content available in CKB BOOST